Top Markets
Coin of the day
BioPlus Acquisition Corp. BioPlus Acquisition Corp.

BioPlus Acquisition Corp.

BIOS
Classement en actions #8010
Currently, BioPlus Acquisition Corp. possesses no major active business... Currently, BioPlus Acquisition Corp. possesses no major active business operations. Its express mandate is to pursue and complete a strategic combination, which may take the form of a merger, share exchange, asset purchase, stock acquisition, reorganization, or similar transaction. This targeted consolidation is specifically aimed at one or more entities within the vibrant life sciences industry. The corporation was formally established in 2021 and maintains its principal executive offices in New York, New York.
Prix de l'action
$10.80
Dernière synchronisation: 2023-10-13
Capitalisation boursière
$1.39B
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange BioPlus Acquisition Corp. (BIOS)
Le prix BIOS avec la capitalisation boursière de B
BioPlus Acquisition Corp. BioPlus Acquisition Corp.
BIOS
$10.80
Capitalisation boursière de BioPlus Acquisition Corp.(BIOS)
Capitalisation boursière: $1.39B
En August 2026, BioPlus Acquisition Corp. a une capitalisation boursière de $1.39B. Cela fait de BioPlus Acquisition Corp. la 8010th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de BioPlus Acquisition Corp. du 2022 au 2026
BIOS par rapport au top 5 des plus populaires stocks
Prix pour BIOS L’actif B La capitalisation boursière de B Résultats
BioPlus Acquisition Corp. BioPlus Acquisition Corp.
$40,981.17 $1.39B
$5.264T +379,355.30%
BioPlus Acquisition Corp. BioPlus Acquisition Corp.
$36,601.19 $1.39B
$4.701T +338,799.86%
BioPlus Acquisition Corp. BioPlus Acquisition Corp.
$32,520.89 $1.39B
$4.177T +301,019.31%
BioPlus Acquisition Corp. BioPlus Acquisition Corp.
$29,719.89 $1.39B
$3.817T +275,084.17%
BioPlus Acquisition Corp. BioPlus Acquisition Corp.
$22,315.50 $1.39B
$2.866T +206,525.01%